10X Genomics, Inc. (TXG)
69.86
-2.53
(-3.50%)
USD |
NASDAQ |
Oct 16, 16:00
69.46
-0.40
(-0.57%)
After-Hours: 20:00
10X Genomics Research and Development Expense (Annual) : 238.63M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 238.63M |
| December 31, 2024 | 264.00M |
| December 31, 2023 | 270.33M |
| December 31, 2022 | 264.27M |
| December 31, 2021 | 211.75M |
| Date | Value |
|---|---|
| December 31, 2020 | 123.38M |
| December 31, 2019 | 83.10M |
| December 31, 2018 | 47.54M |
| December 31, 2017 | 32.16M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Twist Bioscience Corp. | 80.28M |
| Tempus AI, Inc. | 319.03M |
| Personalis, Inc. | 50.26M |
| Intellia Therapeutics, Inc. | 379.09M |
| Alamar Biosciences, Inc. (California) | 37.47M |